Published using Google Docs
Abstract Submission Guidelines NYRIF W24
Updated automatically every 5 minutes

NYRIF Submission Guidelines

https://nyrif.com


Rheumatology fellows from across the U.S. and Canada are invited to submit abstracts showcasing their original basic research, clinical research, or unusual clinical cases. Authors of accepted abstracts will be invited to give a poster presentation at the 2024 NYRIF Symposium - West in San Diego, CA to be held on September 25, 2024. Stipends will be awarded to help offset travel expenses.

ELIGIBLE INDIVIDUALS

EXAMPLE TOPICS

DEADLINE

All abstracts must be received via online submission by 11:59 PM CST on July 31, 2024

INFORMATION REQUIRED FOR SUBMISSION

Note: Contact information should be included in the CV and not in the abstract. 

IMPORTANT: All abstracts must contain a disclosure (COID) stating whether the research was funded or supported in any way by commercial interests (e.g., grants from a pharmaceutical or other company). If there was funding provided by a commercial source, then the abstract must disclose the name of the company and the role of the funding agency. If the  abstract was not funded or supported by any commercial source, then please put, “No Disclosures” either under the Author’s name and institutional affiliation or at the end of the abstract. The presence or absence of commercial support MUST be noted, or the abstract will be REJECTED.

We provide an online Conflict of Interest Disclosure form here: COID Form

SUBMISSION INSTRUCTIONS

Note: Some of the instructions have changed from previous years, so please read them carefully even if you have previously submitted an abstract

The abstract and the presenting author’s curriculum vitae should be submitted electronically online at the NYRIF Registration Portal following the steps below. Detailed instructions regarding the formatting and using the online system can be found at: NYRIF ABSTRACT SUBMISSION INSTRUCTIONS.

For the online submission:

SELECTION OF ABSTRACTS AND AWARDS

ABSTRACT FORMATTING INSTRUCTIONS

Below are the requirements for all abstracts. Failure to follow these instructions may result in the rejection of your abstract.

SUBMISSION POLICIES

  1. “INCOMPLETE” Submissions cannot be processed.
  2. Submission of an abstract constitutes a commitment by the author to present at the symposium.
  3. Submission of an abstract is separate from registration for the NYRIF Symposium. Failure to register for the NYRIF Symposium by July 31, 2024 may jeopardize the inclusion of the abstract.
  4. Please note: all abstracts and posters will appear online and be printed and distributed at the NYRIF Symposium. Poster presentations will also be recorded and available for viewing online by registrants. Please ensure that all necessary permissions for publication have been obtained prior to submission of the abstract.
  5. There is a limit of two abstract submissions per Presenting Author. The submitting author is considered to be the presenting author unless another coauthor is appointed to present and CCR staff is notified of the change by July 31, 2024. The coauthor must meet all NYRIF qualifications and be registered as a NYRIF Symposium attendee.
  6. Only one travel award will be given per person, even if both abstracts are considered to be meritorious.                 
  7. Two investigators may not submit the same research; abstracts that appear to be replicate versions of a single study will be rejected. Submissions will be checked for duplication and both abstracts that appear to be duplicates will be rejected.  
  8. Only one travel stipend will be issued per abstract.
  9. Investigators should submit the abstract to only one category. A submitter must choose the category that best encompasses the abstract’s focus. Be sure to review all the abstract submission options before selecting and starting the submission process. Categories may be added, combined, or deleted at the discretion of NYRIF, depending upon submissions.
  10. Follow all instructions for completing the submission. For research abstracts, be sure to

          structure the content into Background, Methods, Results, and Conclusion sections. Other

      submission types may require a slightly different structure.

  1. Clarity of expression will be considered in the review process. The overall quality of language used should assure comprehension by the reader.
  2. Please write out all non-standard abbreviations the first time they are used, and avoid using abbreviations in the title whenever possible
  3. If authors' names appear on more than one abstract, their names must be spelled identically on each abstract in order to facilitate proper indexing. Do not list authors with initials only.
  4. After July 31, 2024, the system will be closed, and complete abstracts will be forwarded for the review process. An author may not revise or resubmit an abstract in order to make changes or corrections after this deadline.
  5. Proofread abstracts carefully to avoid errors before they are submitted. Your abstract will be published exactly as submitted.
  6. The abstract may be withdrawn or, if already accepted, the error may be indicated during the presentation. If you choose to withdraw an abstract after the submission deadline, this request must be received in writing by nyrif@ccrheumatology.com prior to July 31, 2024. After this date, withdrawals will be accepted, but if the abstracts have already gone to the printer, abstracts may still appear in the final print syllabus.
  7. Adding or removing authors after the submission deadline is not permitted.
  8. All abstracts and posters MUST contain disclosures and a COID form must be completed and accompany the submission. No abstract or poster will be accepted without a Disclosure Statement. If no commercial funds were used for your abstract, then please state, “No Disclosures” either at the beginning under the author’s name and institutional affiliation or at the end of the abstract.